Multidimensional Effects of Soy Isoflavone by Food or Supplements in Menopause Women: A Systematic Review and Bibliometric Analysis
Authors:
- Simone PernaSPSimone Perna
- Davide GuidoDGDavide Guido
Open Access
- 1 November 2016
- journal article
- review article
- Published by SAGE Publications in Natural Product Communications
- Vol. 11 (11) , 1733-1740
Abstract
Isoflavones can exert their action on various levels: on cardiovascular system, bone and muscle health, on cancer, on menopausal symptoms, on obesity, on thyroid and on cognitive function. The aim of this systematic review is to evaluate the multidimensional effects of phytoestrogens in postmenopausal woman, and specifically to explore the impact on scientific literature. A research strategy was planned on PubMed and Scopus by defining the following key words:: menopause, climacteric, soy, isoflavone, phytoestrogens, cardiovascular system, bone mineral density, muscle mass, cancer, thyroid, obesity, cognitive. A total of 43 studies (in humans) were retrieved. The majority (12) describe the applications of soy isoflavones on cardiovascular disease, followed by effects on bone and muscle health (9), and studies concerning their action on menopausal symptoms (7), on cancer (6), on obesity (4), on cognitive function (3) and on thyroid function (2). The citation analysis revealed a growing interest for this topic and the papers on thyroid function are the most cited. Citation trends of the articles regarding the action on cardiovascular disease and on obesity are growing in the last years. Concerning the research areas, this review has assessed the effectiveness of various activities of isoflavones on welfare of menopausal women. In particular, literature show that a specific dosage of isoflavones reduces cardiovascular disease (from 20 to 100 mg/die), may be protective in osteoporosis and muscular fatigue (from 20 to 80 mg/die), may be useful for cancer prevention on endometrium, mammary glands and liver (from 50 to 100 mg/die), might improve menopausal symptoms, particularly in reducing the frequency of hot flashes (from 50 to 120 mg/die), can reduce abdominal fat and circulating inflammatory markers (from 80 to 160 mg/die), may ameliorate the possible interaction between endogenous estrogen and thyroid function (75 mg/die) and improve visual memory (from 50 to 100 mg/die).Keywords
This publication has 40 references indexed in Scilit:
- Combined Nutraceutical Approach to Postmenopausal Syndrome and Vascular Remodeling BiomarkersThe Journal of Alternative and Complementary Medicine, 2013
- Isoflavone supplementation influenced levels of triglyceride and luteunizing hormone in Korean postmenopausal womenArchives of Pharmacal Research, 2013
- Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal womenGynecological Endocrinology, 2012
- Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese womenMenopause, 2012
- Long-term soy isoflavone supplementation and cognition in womenNeurology, 2012
- Effect of soy isoflavone supplementation on nitric oxide metabolism and blood pressure in menopausal womenThe American Journal of Clinical Nutrition, 2012
- Isoflavone Soy Protein Supplementation and Atherosclerosis Progression in Healthy Postmenopausal WomenStroke, 2011
- The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled studyOsteoporosis International, 2011
- The Volume of Nipple Aspirate Fluid Is Not Affected by 6 Months of Treatment with Soy Foods in Premenopausal Women1–4The Journal of Nutrition, 2011
- Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trialAmerican Journal of Obstetrics and Gynecology, 2010